Navigation Links
Macrocyclics apresenta novos produtos
Date:1/10/2014

DALLAS, 10 de janeiro de 2014 /PRNewswire/ -- Macrocyclics, Inc. (uma empresa AREVA Med) anunciou hoje a introdução de quatro novos produtos que vão expandir os aplicativos de imagens PET com cobre-64 e galio-68 usando plataformas de compostos quelato baseadas em NOTA. Além disso, um novo conjugado DOTA baseado em serotonina oferece o potencial para imagens de neurotransmissão serotoninérgica usando um radioisótopo ou com gadolínio através da ressonância magnética.             

(Logo: http://photos.prnewswire.com/prnh/20130523/DA20136LOGO)

Por favor, visitem www.macrocyclics.com para informações detalhadas.

MAIS SOBRE MACROCYCLICS
Macrocyclics é a líder global em tecnologias de agentes quelatos de alto desempenho para medicina desde 1995. Nossa equipe na Macrocyclics dedica-se a fornecer aos clientes agentes quelatos estabelecidos e inovadores para encarar os desafios da imagem molecular e a medicina nuclear. www.macrocyclics.com

MAIS SOBRE A AREVA MED
AREVA Med é uma subsidiária da AREVA especializada no desenvolvimento de terapias inovadoras na luta contra o câncer. AREVA Med desenvolveu novos processos para produzir chumbo-212 (²¹²Pb) de alta pureza, um metal raro que atualmente está no centro das mais promissoras pesquisas de medicina nuclear. Em 2011, AREVA Med adquiriu a Macrocyclics, a líder global em tecnologia de agentes quelatos de alto desempenho. A AREVA Med também está associada com parceiros científicos internacionais, como o National Cancer Institute (NCI), a Universidade do Alabama em Birmingham (UAB) e o Instituto Nacional Francês de Saúde e Pesquisa Médica (Inserm). Em 2012, AREVA Med e Roche entraram em uma aliança estratégica para criar novos tratamentos de radioimunoterapia alpha avançados para selecionar e matar certos tipos de células de câncer muito agressivas. Para mais informações: http://arevamed.areva.com/ ou www.targetedtrials.com.

Macrocyclics
Garry Kiefer
T: +1 972 250 2248
F: +1 972 250 2245
info@macrocyclics.com

AREVA Med
Alison Tise
T: +1 301 841 1673
F: +1 434 382 4250
alison.tise@areva.com

FONTE  Macrocyclics, Inc.

FONTE Macrocyclics, Inc.


'/>"/>
SOURCE Macrocyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Macrocyclics introduces new products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Bernstein Liebhard LLP today announced that a securities class ... for the District of Arizona on ... or entities who purchased common shares of Insys Therapeutics Inc. ... 3, 2015 through January 25, 2016 (the "Class Period").  The ... of the Securities Exchange Act of 1934.  ...
(Date:2/4/2016)... 4, 2016 Wegener Polyangiitis - Pipeline ... Direct,s, ,Wegener Polyangiitis - Pipeline Review, H2 2015, ... pipeline. This report provides comprehensive information on ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ...
(Date:2/4/2016)... 2016 Summary Breast cancer, a malignant ... most common cancer in women worldwide, accounting for 16% ... The number of women diagnosed with breast cancer has ... of deaths has declined due to earlier diagnosis and ... revolutionized in the past four decades, especially with increasing ...
Breaking Medicine Technology:
(Date:2/6/2016)... (PRWEB) , ... February 06, 2016 , ... Shark ... to announce the launch of a new DRTV campaign with Belly Bands. , Having ... tried everything from sprays to puppy pads and find nothing works, get Belly ...
(Date:2/5/2016)... ... ... Love is in the air at King Kullen! The local grocer is ... staple for Valentine’s Day is a must-have, and can be picked up with all ... are long-stem roses available, but also other flower bouquets, elegantly wrapped and ready to ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... and setting the stage for new clinical and scientific initiatives have all marked ... after she was appointed President and CEO of the nation’s oldest cancer center, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Francisco ... micro-needling services in their Napa Valley office. The technique utilizes the body’s own ... Dr. Canales and Dr. Furnas, are part of only a select few cosmetic ...
(Date:2/5/2016)... ... ... After years as an active staff surgeon and having served as the director ... transitioned to chief of the Division of Plastic Surgery at what is now known ... began a second three-year term in January of 2016. , The original selection was ...
Breaking Medicine News(10 mins):